New heart test to save time, money -- and lives

A new test could give doctors a head start in diagnosing those patients most likely to suffer a heart attack.

The test, developed at the University of Leeds, could result in fewer patients needlessly admitted to hospital – enabling medics to concentrate on those most needing their help.

Alistair Hall, Professor of Clinical Cardiology at Leeds, explained: “Casualty departments regularly see patients presenting with chest pains. The highest-risk patients are easy to diagnose and are admitted straight away. Those with no risk of having a heart attack are also easy to spot. It’s the group in between which is hardest to correctly diagnose. Typically patients are admitted for 24 hours while the hospital figures out the cause.”

The most commonly-used diagnostic tool is the troponin test which can detect and evaluate heart injury and separate it from chest pain due to other causes. Essentially if troponin proteins are found in the patient’s blood, then it indicates a heart problem. But Prof Hall explained that the troponin test can give both false negative and false positive results, meaning some patients are unnecessarily admitted, and others wrongly discharged.

A new test, developed at Leeds through research funded by the British Heart Foundation, searches for a heart-type fatty acid-binding protein (H-FABP) which is released into the circulation following heart injury (myocardial ischemia). Prof Hall said: "The H-FABP test is a major advance on what we had before. It appears to be able to detect milder and earlier degrees of heart injury than do current tests which detect heart cell death.”

The team’s findings are published in the American Journal of Cardiology: "Our paper shows that it is possible to be more effective in matching life-saving treatments to the patients with heart attacks who most likely to benefit from them," said Prof Hall.

The test also enables medics to identify patients whose chest pains are an indication that they are susceptible to heart attack in the weeks and months ahead. “If you can pick these problems up in advance you could have a three-month head start in putting prevention in place,” he added.

"The study was conducted in UK in the context of a national health care system that forces hard decisions to be made regard the best use of limited resources. This blood test, which will cost about £10, could be used by ambulance crews to test people on the way to hospital. This test will enable us to send the right people home earlier and make sure we aren’t admitting people who don’t need to be admitted.

"We are excited about these findings as we believe that they will help us to provide very real benefits for patients and those who care for them."

Professor Peter Weissberg, Medical Director at the British Heart Foundation (BHF), said: "Currently doctors rely on tests such as an electrocardiogram (ECG) and blood tests to know if a patient with chest pain has suffered any heart damage.

“This new blood test would appear to be able to more accurately identify patients with heart damage at an earlier course of their illness. If further research confirms its superiority over current tests, it has the potential to improve diagnosis and identify those people who require intensive investigation and treatment to prevent further problems."

Source: University of Leeds

Related stories:

Liver disease plagues obese adolescents
(AP) -- In a new and disturbing twist on the obesity epidemic, some overweight teenagers have severe liver damage caused by too much body fat, and a handful have needed liver transplants.
At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better
Ten million Americans have peripheral arterial disease (PAD), and research shows that the highest risk populations include African-Americans (twice as likely to develop clogged leg arteries), seniors (12-20 percent develop PAD) and diabetics (one in three who are over the age of 50 develop PAD). Legs for Life®—a community health and public information program—recommends that older Americans take its free, online self-assessment quiz.
Watch out for drug names that look, sound alike
(AP) -- Take the generic drug clonidine for high blood pressure? Double-check that you didn't leave the drugstore with Klonopin for seizures, or the gout medicine colchicine.
Researchers devise means to create blood by identifying earliest stem cells
Johns Hopkins researchers have discovered the earliest form of human blood stem cells and deciphered the mechanism by which these embryonic stem cells replicate and grow. They also found a surprising biological marker that pinpoints these stem cells, which serve as the progenitors for red blood cells and lymphocytes.
Eyes turn to dawn of 'visual computing'
Lifelike graphics are breaking free of elite computer games and spreading throughout society in what industry insiders proclaim is the dawning of a "visual computing era."
FDA OKs blood test for heart transplant rejection
(AP) -- Government regulators on Wednesday cleared the way for broader use of a blood test that can spare heart transplant patients the ordeal of repeated biopsies to check if their bodies are rejecting the new organ.
Clinical study to examine role of vitamin D in kidney disease
Vitamin D is the key to preventing rickets and osteoporosis, but Rockefeller University scientists suspect it may also play a role in heading off atherosclerosis in people with chronic kidney disease.
Biodegradable polymers show promise for improving treatment of acute inflammatory diseases
A family of biodegradable polymers called polyketals and their derivatives may improve treatment for such inflammatory illnesses as acute lung injury, acute liver failure and inflammatory bowel disease by delivering drugs, proteins and snips of ribonucleic acid to disease locations in the body.

News discussion:

Medicine & Health news